Abu Dhabi: The Emirates Drug Establishment (EDE) has approved a new therapeutic use for Foundayo (orforglipron), an oral medication developed by US pharmaceutical company Eli Lilly, to treat type 2 diabetes in adults, making the UAE the third country in the world to authorise the medicine for this purpose, according to the regulator.